Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 1,588 | 1,996 | 1,104 | 1,066 | 0 |
| Operating Income | -1,588 | -1,996 | -1,104 | -1,066 | N/A |
| Interest Expense | 6 | 3 | 4 | 4 | 0 |
| Other Income | 640 | 239 | 649 | -820 | 0 |
| Pre-tax Income | -954 | -1,760 | -459 | -1,890 | 0 |
| Income Tax | -74 | -89 | -40 | -92 | N/A |
| Net Income Continuous | -880 | -1,671 | -419 | -1,798 | N/A |
| Net Income | $-880 | $-1,671 | $-419 | $-1,798 | $N/A |
| EPS Basic Total Ops | -2,162.16 | -5,045.04 | -1,441.44 | -6,486.49 | N/A |
| EPS Basic Continuous Ops | -2,200.00 | -5,088.62 | -1,495.26 | -6,514.13 | N/A |
| EPS Diluted Total Ops | -2,162.16 | -5,045.04 | -1,441.44 | -6,486.49 | N/A |
| EPS Diluted Continuous Ops | -2,200.00 | -5,088.62 | -1,495.26 | -6,514.13 | N/A |
| EBITDA(a) | $-1,588 | $-1,996 | $-1,104 | $-1,066 | $N/A |